Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

(2019) Marta Alvarez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks

(2019) Rima K. Acosta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naïve and Experienced Individuals from Western India

(2019) SANTOSH KARADE et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle

(2019) Rachel Van Duyne et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel

(2018) Huldrych F Günthard et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada

(2018) Hezhao Ji et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing

(2018) T Nguyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir

(2017) Marine Perrier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

(2017) Paul E Sax et al.   LANCET

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

(2017) Joel Gallant et al.   LANCET

Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome

(2017) Michael E. Abram et al.   PLoS One

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors

(2017) Isabelle Malet et al.   mBio

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics

(2016) Reshma Kassanjee et al.   AIDS

Rare emergence of drug resistance in HIV-1 treatment -naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide

(2016) Nicolas A. Margot et al.   HIV CLINICAL TRIALS

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015

(2016) Duncan Churchill et al.   HIV MEDICINE

Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom

(2016) A Tostevin et al.   HIV MEDICINE

Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK

(2016) Emma Cunningham et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan

(2016) Sui-Yuan Chang et al.   Scientific Reports

Transmission of HIV drug resistance

(2015) Anna Maria Geretti et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Brief Report

(2015) Sharon Walmsley et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Primary resistance to integrase strand-transfer inhibitors in Europe: Table 1.

(2015) M. Casadellà et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

(2015) Tomas Doyle et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Assessment of the Utility of Whole Genome Sequencing of Measles Virus in the Characterisation of Outbreaks

(2015) Ana Raquel Penedos et al.   PLoS One

Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007–2013

(2014) Joanne D Stekler et al.   ANTIVIRAL THERAPY

Trimmomatic: a flexible trimmer for Illumina sequence data

(2014) Anthony M. Bolger et al.   BIOINFORMATICS

Recent infection testing algorithm (RITA) applied to new HIV diagnoses in England, Wales and Northern Ireland, 2009 to 2011

(2014) A Aghaizu et al.   Eurosurveillance

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

(2014) Alessandro Cozzi-Lepri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Low-Frequency NNRTI-Resistant HIV-1 Variants and Relationship to Mutational Load in Antiretroviral-Naïve Subjects

(2014) Shaili Gupta et al.   Viruses-Basel

Emerging patterns and implications of HIV-1 integrase inhibitor resistance

(2012) Anna Maria Geretti et al.   CURRENT OPINION IN INFECTIOUS DISEASES

SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing

(2012) Anton Bankevich et al.   JOURNAL OF COMPUTATIONAL BIOLOGY

Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies

(2012) Yen T. Duong et al.   PLoS One

Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure

(2011) Jonathan Z. Li   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

New technology to detect low-level drug-resistant HIV variants

(2010) Arjet Gega et al.   Future Virology

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

(2009) R. J. Gifford et al.   BIOINFORMATICS

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

(2009) Diane E. Bennett et al.   PLoS One